Home › Novartis sees Q4 profit rise 72 per cent to $2.1B without charges
 

Keywords :   


Novartis sees Q4 profit rise 72 per cent to $2.1B without charges

2013-01-23 10:10:28| Biotech - Topix.net

The result is 72 per cent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million charge after ending its clinical study into wider uses of the hypertension drug Tekturna.

Tags: without rise charges profit

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »